Muratori, P.; Lalanne, C.; Fabbri, A.; Cassani, F.; Lenzi, M.; Muratori, L., Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype, «ALIMENTARY PHARMACOLOGY & THERAPEUTICS», 2015, 41, pp. 1281 - 1287 [Scientific article]
Bruno, S; Bollani, S.; Zignego, A.L.; Pascasio, J.M.; Magni, C.; Ciancio, A.; Caremani, M.; Mangia, A.; Marenco, S.; Piovesan, S.; Chemello, L.; Babudieri, S.; Moretti, A.; Gea, F.; Colletta, C.; Perez-Alvarez, R.; Forns, X.; Larrubia, J.R.; Arenas, J.; Crespo, J.; Calvaruso, V.; Ceccherini Silberstein, F.; Maisonneuve, P.; Craxì, A.; Calleja, J.L.; Di Marco, V.; Monti, M.; Rizzardini, G.; Landonio, S.; Rizzetto, M.; Lapini, L.E.; Piazzolla, V.; Picciotto, A.; Alberti, A.; Cavaletto, L.; Koch, M.; Massari, M.; Muratori, L.; Cipriano, V.; Montineri, A.; Iacobello, C.; Fangazio, S.; Pirisi, M.; Colombo, A.; Bellati, G.; Mazzotta, F.; Pierotti, P.; Traverso, A.; Serviddio, G.; Russello, M.; Santantonio, T.; Drenaggi, D.; Marchionne, E.; Zuin, M.; Delliponti, M.; Farina, F.; Andreone, P.; Scuteri, A.; Galli, M.; Giannini, E.G.; Nerli, A.; Carbonai, S.; Coppola, N.; Montalbano, M.; Portelli, V.; Di Biagio, A.; Nicolini, L.A.; Mastroianni, C.; Madonia, S.; Licata, A.; Montalto, G.; Giannit, Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program, «JOURNAL OF VIRAL HEPATITIS», 2015, 22, pp. 469 - 480 [Scientific article]
Muratori L; Masi C; Muratori P., Anti-ribosomal P protein antibody: an autoreactivity devoid of prognostic value in patients with autoimmune hepatitis., «LIVER INTERNATIONAL», 2014, 34, pp. 1446 - 1446 [Comment or similar]
Ozaslan, E; Efe, C; Heurgué-Berlot, A; Kav, T; Masi, C; Purnak, T; Muratori, L; Ustündag, Y; Bresson-Hadni, S; Thiéfin, G; Schiano, Td; Wahlin, S; Muratori, P., Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis., «CLINICAL GASTROENTEROLOGY AND HEPATOLOGY», 2014, 12, pp. 863 - 869 [Scientific article]
P. Colombatto;M. R. Brunetto;A. M. Maina;V. Romagnoli;P. Almasio;M. G. Rumi;A. Ascione;G. Pinzello;M. Mondelli;L. Muratori;R. Rappuoli;D. Rosa;M. Houghton;S. Abrignani;F. Bonino, HCV E1E2-MF59vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial, «JOURNAL OF VIRAL HEPATITIS», 2014, 21, pp. 458 - 465 [Scientific article]
Invernizzi, Pietro; Muratori, Luigi, Nuclear Envelope Protein Autoantibodies/Antilamin Autoantibodies (Chapter 26), AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO, Elsevier, 2014, pp. 5 . [Research monograph]
C. Efe;E. Ozaslan;A. Heurgué-Berlot;T. Kav;C. Masi;T. Purnak;M. Torgutalp;L. Muratori;S. Bresson-Hadni;G. Thiéfin;T. D. Schiano;P. Muratori;S. Wahlin, Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis., «EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY», 2014, 26, pp. 532 - 537 [Scientific article]
Muratori, Luigi; Invernizzi, Pietro, Smooth Muscle Autoantibodies (Chapter 58), in: Autoantobodies, AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO, Elsevier, 2014, pp. 491 - 495 [Chapter or essay]
Cumali Efe;Ersan Ozaslan;Staffan Wahlin;Tugrul Purnak;Luigi Muratori;Chiara Quarneti;Osman Yüksel;Paolo Muratori, Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study, «LIVER INTERNATIONAL», 2013, 33, pp. 190 - 196 [Scientific article]
Cumali Efe;Staffan Wahlin;Ersan Ozaslan;Tugrul Purnak;Luigi Muratori;Chiara Quarneti;Gonca Tatar;Halis Simsek;Paolo Muratori;Thomas D. Schiano, Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C, «SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY», 2013, 48, pp. 504 - 508 [Scientific article]
SP Kar; MF Seldin; W Chen; E Lu; GM Hirschfield;, P Invernizzi; J Heathcote; D Cusi; the Italian PBC Genetics Study Group [..; P Andreone; L Muratori; P Muratori; ..]; ME Gershwin; KA Siminovitch; CI Amos, Pathway-based analysis of primary biliary cirrhosis genome-wide association studies, «GENES AND IMMUNITY», 2013, 14, pp. 179 - 186 [Scientific article]
K. Zachou;P. Muratori;G. K. Koukoulis;A. Granito;N. Gatselis;A. Fabbri;G. N. Dalekos;L. Muratori, Review article: autoimmune hepatitis - current management and challenges, «ALIMENTARY PHARMACOLOGY & THERAPEUTICS», 2013, 38, pp. 887 - 913 [Scientific article]
Luigi Muratori;Maria Serena Longhi, The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies, «JOURNAL OF AUTOIMMUNITY», 2013, 46, pp. 74 - 80 [Scientific article]
Granito A; Muratori P; Quarneti C; Pappas G; Cicola R; Muratori L., Antinuclear antibodies as ancillary markers in primary biliary cirrhosis., «EXPERT REVIEW OF MOLECULAR DIAGNOSTICS», 2012, 12, pp. 65 - 74 [Scientific article]
S. Righi;E. Fiorini;C. De Molo;V. Cipriano;F. Cassani;L. Muratori;M. Lenzi;A.M. Morselli Labate;C. Serra, ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study, «JOURNAL OF ULTRASOUND», 2012, 15, pp. 226 - 231 [Scientific article]
